TMEM28 Inhibitors
TMEM28 inhibitors encompass a variety of chemical compounds that interfere with specific signaling pathways and biological processes, leading to a decrease in the functional activity of TMEM28. For instance, certain compounds target the mTOR signaling pathway, which is essential for cell cycle progression and could possibly affect TMEM28 if it is involved in related transduction mechanisms. Inhibition of this pathway results in the dephosphorylation of downstream targets that could be linked to TMEM28 activity. Other inhibitors act on kinase signaling, which is a fundamental process in phosphorylation-dependent regulation of proteins. The presence of kinase inhibitors can lead to a broad-spectrum decrease in kinase activity, thereby potentially influencing the phosphorylation state and thus the function of TMEM28. These inhibitors can obstruct kinases that might control the phosphorylation status and consequent activity of TMEM28.
Additional inhibitors have been identified that specifically target the PI3K/Akt and MEK/ERK pathways, which are crucial for multiple cellular processes, including growth and survival. Inhibition of these pathways might impact TMEM28 if it is regulated via these signaling cascades. Moreover, certain compounds inhibit the Raf-1 kinase, the p38 MAPK, and the MEK5/ERK5 pathways, which could lead to a decrease in the regulatory activity exerted on TMEM28. Furthermore, there are inhibitors that disrupt the Rac1-mediated cytoskeletal reorganization and BMP receptor signaling, which could consequently attenuate TMEM28 activity if it is a part of these cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that leads to the dephosphorylation and inactivation of downstream targets crucial for cell cycle progression. TMEM28, being a transmembrane protein, could be involved in signal transduction pathways that are affected by altered cell cycle dynamics, resulting in its functional inhibition. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor which impedes the activity of a wide range of kinases. TMEM28, if associated with kinase signaling pathways, would experience decreased signaling activity as a result of staurosporine binding and inhibiting kinases that may phosphorylate or otherwise regulate TMEM28. | ||||||
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
A selective NUAK1/2 kinase inhibitor that could reduce the phosphorylation of proteins associated with this kinase, potentially including TMEM28 if its activity is NUAK1/2-dependent. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor which could prevent the phosphorylation of substrates involved in the JNK signaling pathway. If TMEM28 is modulated by JNK signaling, its inhibition via SP600125 would lead to decreased TMEM28 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could disrupt the PI3K/Akt signaling pathway, potentially affecting the functional regulation of TMEM28 if it is involved in this pathway. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
A Raf-1 kinase inhibitor, which could indirectly decrease the activity of TMEM28 by inhibiting a kinase that may take part in its regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that would impede the MAPK signaling pathway. If TMEM28's function is modulated by this pathway, then inhibition by SB 203580 would result in its decreased activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An MEK inhibitor that could prevent the activation of ERK, potentially leading to reduced regulatory phosphorylation events that could involve TMEM28. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor which could decrease ERK-mediated phosphorylation events, potentially affecting TMEM28 if it is part of this signaling cascade. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $224.00 $386.00 | 5 | |
A selective inhibitor of MEK5, which could decrease the activity of ERK5 and its downstream signaling components. This could affect TMEM28 if it is regulated by the MEK5/ERK5 pathway. | ||||||